August 10, 2017
Opting for cheaper prescription drugs seems like an obvious way to cut health care costs. The assumption has led health plans to employ utilization management techniques with increasing frequency in recent years. And it’s given rise to a newer phenomenon known as “non-medical switching,” where health plans exclude a drug from coverage or increase patients’ out-of-pocket burden in hopes of persuading patients to take a less expensive drug.
August 8, 2017
Could the solution to America’s opioid overdose crisis be as close as the nearest yoga studio?
August 6, 2017
Respiratory illnesses are pervasive, chronic conditions that exist quietly in millions of Americans. Patients manage their breathing with varying degrees…
August 2, 2017
Are coupons that help patients afford their co-pays a help – or a hindrance – in the age of innovative but costly prescription medications? A new “Co-Pay Coupons” Fast Facts from the Institute for Patient Access explores why coupons and co-pay assistance programs remain a source of debate – and how they impact patients’ ability to access the medication their doctor prescribes.
August 1, 2017
People are living longer, healthier lives today with the help of advanced medicine. But innovative drugs can be expensive. Insurance…
August 1, 2017
Health benefits designs in both private and public health insurance programs include mechanisms to control the costs of care, resulting…
August 1, 2017
Non-medical switching occurs when health plans drive stable patients to switch from their current medication to a less expensive alternative.…
July 28, 2017
Most all of us know someone living in a long-term care facility – a friend, a former neighbor, a family member. But not all may be aware of a recent debate about the use of a certain type of medication – antipsychotic medication – for seniors living in these facilities.
July 27, 2017
Nearly one in five Americans with hepatitis C spends time behind bars each year, making the prison system an opportune environment to test and cure potential transmitters of the disease.
July 25, 2017
Accessing innovative cardiovascular drugs may soon get harder.
